These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10368852)

  • 1. Clinical outcome to clozapine treatment in chronic psychiatric inpatients.
    Advokat CD; Bertman LJ; Comaty JE
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):1-14. PubMed ID: 10368852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching from clozapine to olanzapine in treatment-refractory schizophrenia: safety, clinical efficacy, and predictors of response.
    Henderson DC; Nasrallah RA; Goff DC
    J Clin Psychiatry; 1998 Nov; 59(11):585-8. PubMed ID: 9862604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.
    Umbricht DS; Wirshing WC; Wirshing DA; McMeniman M; Schooler NR; Marder SR; Kane JM
    J Clin Psychiatry; 2002 May; 63(5):420-4. PubMed ID: 12019667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind study of clozapine dose response in chronic schizophrenia.
    Simpson GM; Josiassen RC; Stanilla JK; de Leon J; Nair C; Abraham G; Odom-White A; Turner RM
    Am J Psychiatry; 1999 Nov; 156(11):1744-50. PubMed ID: 10553738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with clozapine in 55 cases of treatment-resistant schizophrenia].
    Enomoto T; Ito T; Sekine K; Yasui R; Ashizawa Y; Uju Y; Hayakawa T; Tsukada K
    Seishin Shinkeigaku Zasshi; 2013; 115(9):953-66. PubMed ID: 24228473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of clozapine on symptom clusters in treatment-refractory patients.
    Abraham G; Nair C; Tracy JI; Simpson GM; Josiassen RC
    J Clin Psychopharmacol; 1997 Feb; 17(1):49-53. PubMed ID: 9004057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
    Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
    J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of smoking cessation on psychiatric inpatients treated with clozapine or olanzapine.
    Cole ML; Trigoboff E; Demler TL; Opler LA
    J Psychiatr Pract; 2010 Mar; 16(2):75-81. PubMed ID: 20511731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].
    Jalenques I; Coudert AJ
    Acta Psychiatr Belg; 1992; 92(6):323-38. PubMed ID: 1364281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
    Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
    Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
    Pickar D; Bartko JJ
    Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine.
    Sumiyoshi T; Hasegawa M; Jayathilake K; Meltzer HY
    Psychiatry Res; 1997 Mar; 69(2-3):113-21. PubMed ID: 9109179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
    Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose related response to clozapine in a state psychiatric hospital population: a naturalistic study.
    Gordon BJ; Milke DJ
    Psychiatr Q; 1996; 67(1):65-74. PubMed ID: 8623040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
    J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS
    J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.